Conversely, patients with a genetic score indicating decreased CETP function had significantly reduced sepsis-related mortality in the UK Biobank and iSPAAR cohorts, and mouse models of sepsis treated with the CETP inhibitor anacetrapib had higher HDL-C levels and better survival relative to those treated with placebo.34 This evidence concerns the gene CETP and Sepsis.